Fundai

Iran Antibiotic Manufacturing Company (BIUTIK) cash flow statement

Operating, investing and financing cash flows, and the closing balance

Ticker
BIUTIK
Industry
Pharmaceuticals
Market
Iran Fara Bourse

Latest periods

Latest 6-month periods, in million rials
ItemTo 1405/06/31To 1404/06/31To 1403/06/31To 1402/06/31To 1401/06/31To 1400/06/31
Cash generated from operations773,120225,2791,881,171-2,266,85133,198-128,846
Cash payments for income tax-464,383-626,540-87,538-68,378-40,456-32,122
Net cash inflow (outflow) from operating activities308,737-401,2611,793,633-2,335,229-7,258-160,968
Cash receipts from sale of property, plant and equipment83,0950009597
Cash payments for purchase of property, plant and equipment-160,802-77,421-114,958-104,875-47,575-26,125
Cash payments for purchase of intangible assets-6000-1,560-675-3,560-1,191
Net cash inflow (outflow) from investing activities-78,307-76,369-58,574-125,050-42,471-68,989
Net cash inflow (outflow) before financing activities230,430-477,6301,735,059-2,460,279-49,729-229,957
Cash receipts from sale of treasury shares9,5093,0800000
Cash payments for purchase of treasury shares-1,901-3,3550000
Cash receipts from facilities3,200,0004,600,0001,000,0003,443,000500,000462,500
Cash payments for principal of loans-4,513,439-2,507,128-2,890,520-824,229-360,887-432,435
Cash payments for interest on loans-741,008-443,239-386,684-88,892-45,866-45,944
Cash payments for dividends-159,491-547,612-240,000-366,5910-167,500
Net cash inflow (outflow) from financing activities-2,206,3301,101,746-2,517,2042,163,288-94,724-183,379
Net increase (decrease) in cash-1,975,900624,116-782,145-296,991-144,453-413,336
Cash balance at beginning of year2,390,9351,766,741905,4371,992,483502,187485,575
Effect of changes in exchange rates431788113301-1
Cash balance at end of year415,4662,390,935123,3731,695,505358,03572,238

Reporting periods

29 periods are on file for this report, from the period ending 1395/12/30 to the period ending 1405/06/31.